Asthma Control LevelNCT01298739
Asthma Control Study 2011
An observational study of Asthma Control Level, run by AstraZeneca at 53 sites in Hungary.
Trial summary
Asthma control study 2011 Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Asthma Control Level
- How many people
- 1,524 participants
- Where
- 53 sitesHungary
- Study dates
- Feb 2011to Oct 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Asthmatic patients above 18 y
Who may be able to join
- Asthmatic patients above 18 y
Who cannot join
- COPD
- pulmonary cancer
- pulmonary tuberculosis
Trial locations and contacts
53 sites in 1 country.
53 sites in 1 country
Hungary53 sites
Research Site
Adásztevel, Adásztevel
Research Site
Ajka, Ajka
Research Site
Albertirsa, Albertirsa
Research Site
Baja, Baja
Research Site
Balatonendréd, Balatonendréd
Research Site
Békés, Bekes County
Research Site
Békéscsaba, Békéscsaba
Research Site
Budajenő, Budajenő
Research Site
Budakeszi, Budakeszi
Research Site
Budapest, Budapest
Research Site
Celldömölk, Celldömölk
Research Site
Dabas, Dabas
Research Site
Debrecen, Debrecen
Research Site
Dombóvár, Dombóvár
Research Site
Dunaújváros, Dunaújváros
Research Site
Edelény, Edelény
Research Site
Eger, Eger
Research Site
Encs, Encs
Research Site
Esztergom, Esztergom
Research Site
Gyöngyös, Gyöngyös
Research Site
Győr, Győr
Research Site
Gyula, Gyula
Research Site
Hatvan, Hatvan
Research Site
Hódmezővásárhely, Hódmezővásárhely
Research Site
Kaposvár, Kaposvár
Research Site
Kecskemét, Kecskemét
Research Site
Kisbér, Kisbér
Research Site
Kiskunfélegyháza, Kiskunfélegyháza
Research Site
Kiskunhalas, Kiskunhalas
Research Site
Komárom, Komárom
Research Site
Körmend, Körmend
Research Site
Lenti, Lenti
Research Site
Mátraháza, Mátraháza
Research Site
Miskolc, Miskolc
Research Site
Monor, Monor
Research Site
Mór, Mór
Research Site
Mosdós, Mosdós
Research Site
Nagykanizsa, Nagykanizsa
Research Site
Nyíregyháza, Nyíregyháza
Research Site
Paks, Paks
Research Site
Pécs, Pécs
Research Site
Sopron, Sopron
Research Site
Szarvas, Szarvas
Research Site
Szeged, Szeged
Research Site
Székesfehérvár, Székesfehérvár
Research Site
Szombathely, Szombathely
Research Site
Tata, Tata
Research Site
Tatabánya, Tatabánya
Research Site
Tiszaújváros, Tiszaújváros
Research Site
Törökbálint, Törökbálint
Research Site
Törökszentmiklós, Törökszentmiklós
Research Site
Veszprém, Veszprém megye
Research Site
Zalaegerszeg, Zalaegerszeg
About this study
Asthma control study 2011
- Conditions
- Asthma Control Level
- Keywords
- asthma control level , ACQ
What is being measured
The primary outcome is the main question the study is designed to answer.
Asthma control level
Measured: 2 times
Secondary outcomes (1)
Routine Therapeutical habits in control maintenance
Measured: 2 time
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Feb 2011 (estimated)
- Study startFeb 2011
- Primary completionOct 2011
- Study completionOct 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Asthma Control LevelStudies of the same condition, open and under way.
- More trials run by AstraZenecaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,524 participants (actual)
Sponsor and investigators
- Lead sponsor
- AstraZeneca
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- György Losonczy, MD PHD, Principal investigator, Semmelweis University Budapest Pulmonology Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01298739
- Sponsor's protocol ID
- NIS-RHU-XXX-2011/1
- Status last verified
- Oct 2011
- First submitted
- 16 Feb 2011
- Last updated
- 25 Oct 2011
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Oct 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Asthma Control Study 2011
- ClinicalTrials.gov ID
- NCT01298739
- Acronym / sponsor ID
- NIS-RHU-XXX-2011/1
- Conditions
- Asthma Control Level
- Keywords
- asthma control level , ACQ
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,524 participants (actual)
- Lead sponsor
- AstraZenecaIndustry (pharma, biotech, devices)
- Study start
- Feb 2011
- Primary completion
- Oct 2011 (actual)
- Study completion
- Oct 2011 (actual)
- First posted
- 18 Feb 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Asthma control study 2011
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Asthmatic patients above 18 y
Key inclusion criteria (1 listed)
- Asthmatic patients above 18 y
Key exclusion criteria (3 listed)
- COPD
- pulmonary cancer
- pulmonary tuberculosis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Asthma control level
Time frame: 2 times
1 secondary outcome
Routine Therapeutical habits in control maintenance
Time frame: 2 time
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Oct 2011.
Related trials for Asthma Control Level
RecruitingPhase 4
45th Multicenter Airway Research Collaboration
Asthma Acute, Asthma Exacerbation
RecruitingObservational study
Remission in Adults With Severe Asthma in Thailand
Severe Asthma, Asthma Control Level
RecruitingObservational study
Remission in Adults With Mild-to-moderate Asthma in Thailand
Asthma, Mild-to-moderate Asthma
Not yet recruiting
Effects of Buteyko Breathing Exercise in Children With Uncontrolled Asthma
Breathing Techniques, Asthma Control Level
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
György Losonczy, MD PHD principal investigator
Semmelweis University Budapest Pulmonology Clinic
53 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Asthma Control Level, run by AstraZeneca at 53 sites in Hungary.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Oct 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 53 sites in Hungary. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Asthma control level (time frame: 2 times). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Oct 2011; AzTrials last refreshed its copy on 28 Oct 2026.